36th European-Organisation-for-Research-and-Treatment-of-Cancer / National-Cancer-Institute / American-Association-for-Cancer-Research Symposium on Molecular Targets and Cancer Therapeutics (EORTC/NCI/AACR), 2024
JANOVSKÁ, Pavlína; Tomasz Witold RADASZKIEWICZ; P PROCHAZKOVA; Ingrid PRIŠTICOVÁ; Hana PLEŠINGEROVÁ; Martin ČULEN; Michal ŠMÍDA; Daniel BUŠA; Adriana LADUNGOVÁ; Lukáš MAIER; Štěpán HAVEL; Jiří MAYER; A SCHEER; Kamil PARUCH a Vítězslav BRYJA. Novel casein kinase 1 alpha inhibitors for the treatment of resistant AML and solid tumors. In 36th European-Organisation-for-Research-and-Treatment-of-Cancer / National-Cancer-Institute / American-Association-for-Cancer-Research Symposium on Molecular Targets and Cancer Therapeutics (EORTC/NCI/AACR). 2024. Dostupné z: https://doi.org/10.1016/j.ejca.2024.114893.
@proceedings{2481479, author = {Janovská, Pavlína and Radaszkiewicz, Tomasz Witold and Prochazkova, P and Prišticová, Ingrid and Plešingerová, Hana and Čulen, Martin and Šmída, Michal and Buša, Daniel and Ladungová, Adriana and Maier, Lukáš and Havel, Štěpán and Mayer, Jiří and Scheer, A and Paruch, Kamil and Bryja, Vítězslav}, booktitle = {36th European-Organisation-for-Research-and-Treatment-of-Cancer / National-Cancer-Institute / American-Association-for-Cancer-Research Symposium on Molecular Targets and Cancer Therapeutics (EORTC/NCI/AACR)}, doi = {https://doi.org/10.1016/j.ejca.2024.114893}, language = {eng}, title = {Novel casein kinase 1 alpha inhibitors for the treatment of resistant AML and solid tumors}, url = {https://www.ejcancer.com/article/S0959-8049(24)01584-3/abstract}, year = {2024} }
TY - CONF ID - 2481479 AU - Janovská, Pavlína - Radaszkiewicz, Tomasz Witold - Prochazkova, P - Prišticová, Ingrid - Plešingerová, Hana - Čulen, Martin - Šmída, Michal - Buša, Daniel - Ladungová, Adriana - Maier, Lukáš - Havel, Štěpán - Mayer, Jiří - Scheer, A - Paruch, Kamil - Bryja, Vítězslav PY - 2024 TI - Novel casein kinase 1 alpha inhibitors for the treatment of resistant AML and solid tumors UR - https://www.ejcancer.com/article/S0959-8049(24)01584-3/abstract ER -
JANOVSKÁ, Pavlína; Tomasz Witold RADASZKIEWICZ; P PROCHAZKOVA; Ingrid PRIŠTICOVÁ; Hana PLEŠINGEROVÁ; Martin ČULEN; Michal ŠMÍDA; Daniel BUŠA; Adriana LADUNGOVÁ; Lukáš MAIER; Štěpán HAVEL; Jiří MAYER; A SCHEER; Kamil PARUCH a Vítězslav BRYJA. Novel casein kinase 1 alpha inhibitors for the treatment of resistant AML and solid tumors. In \textit{36th European-Organisation-for-Research-and-Treatment-of-Cancer / National-Cancer-Institute / American-Association-for-Cancer-Research Symposium on Molecular Targets and Cancer Therapeutics (EORTC/NCI/AACR)}. 2024. Dostupné z: https://doi.org/10.1016/j.ejca.2024.114893.